Does CRISPR-Cas immunity limit the efficacy of phage therapy?

Project: Research project (funded)Research

Project Details

StatusFinished
Effective start/end date1/02/2131/01/24

Funding

  • BBSRC (BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL): £8,863.20